Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

CGEN Relative to the S&P 500

CGEN Relative to the Sector

% of Revenue Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Compugen Ltd. (NASD:CGEN) seasonal charts above shows that a Buy Date of November 9 and a Sell Date of January 30 has resulted in a geometric average return of 13.51% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 15 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 27.73% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses on research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel.

To download CGEN seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: CGEN